| Article
Elimination of X-Waiver and Training Requirements for New MATE ACT
As a healthcare provider, you've probably heard about the Medication Access and Training Expansion (MATE) Act but may be unclear about precisely what it means for you. This comprehensive overview can help you better understand it...
| Article
The U.S. Department of Health & Human Services, National Institutes of Health released a press release dated September 18, 2023, detailing a study that suggests that higher buprenorphine doses are associated with improved retention in treatment for opioid use disorder.
According to the US...
| Article
While the disease of addiction knows no boundaries, unfortunately treatment for opioid use disorder seems to. In yet another example of healthcare inequity, Black and Latin patients have less access than Whites to buprenorphine. Why? That’s what researchers at the University of Washington hope to...
| Article
JAMA reports a noted increase in opioid use disorder treatments in those enrolled in Medicaid. The study looked at over a million enrollees from 11 states: medication treatment prevalence in 2014 was 47.8% and in 2018, 57.1%. Of note, use of OUD medication was higher in pregnant women and white...
| Article
Challenges. That’s what prescribers are facing when prescribing buprenorphine. They face barriers, hurdles, difficulties helping their patients overcome opioid use disorder. Even though things are changing—the federal government has removed some barriers, such as requiring special training for...
| Article
Due to the opioid epidemic and public health crisis, opioid use disorder treatment is greatly needed. In an effort to make the use of buprenorphine easier, the Department of Health and Human Services (HHS) plans to no longer require an X-waiver for prescriptions. By deregulating buprenorphine...
| Article
From the journal Drug and Alcohol Dependence. Highlights:
• The number of buprenorphine prescriptions dispensed increase 9.1% from from 2017 to 2018.
• Buprenorphine prescribing by nurse practitioners and physician assistants increased the most.
• Recent legislative and regulatory efforts...
| Article
Newswise — A new study led by University of Kentucky researcher April Young and Emory University researcher Hannah Cooper shows that a number of pharmacies in the Appalachian region of Kentucky are limiting the dispensing of buprenorphine, a medication used to treat opioid use disorder (OUD). This...
| Article
Newswise — Though research shows that medication-assisted treatment can help people who are addicted to opioids, the three drugs approved by the Food and Drug Administration (FDA) are underused, according to a review of current medical data on opioid addiction in the U.S. This review appears in the...
| Podcast
With our current climate of opioid overuse and increasing opioid related deaths, alternatives to pure mu opioids are necessary. Buprenorphine, an important weapon in the arsenal for management of substance use disorder, is now rising in popularity as an opioid option for chronic pain. Evidence has...